142 related articles for article (PubMed ID: 32246324)
21. Editor's Choice - A Systematic Review and Meta-Analysis of the Efficacy and Safety of Anticoagulation in the Treatment of Venous Thromboembolism in Patients with Cancer.
Kirkilesis GI; Kakkos SK; Tsolakis IA
Eur J Vasc Endovasc Surg; 2019 May; 57(5):685-701. PubMed ID: 31097186
[TBL] [Abstract][Full Text] [Related]
22. Benefit and risk of primary thromboprophylaxis in ambulatory patients with advanced pancreatic cancer receiving chemotherapy: a systematic review and meta-analysis of randomized controlled trials.
Tun NM; Guevara E; Oo TH
Blood Coagul Fibrinolysis; 2016 Apr; 27(3):270-4. PubMed ID: 26963028
[TBL] [Abstract][Full Text] [Related]
23. Editor's Choice - efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials.
Kakkos SK; Kirkilesis GI; Tsolakis IA
Eur J Vasc Endovasc Surg; 2014 Nov; 48(5):565-75. PubMed ID: 24951377
[TBL] [Abstract][Full Text] [Related]
24. Extended-duration versus short-duration pharmacological thromboprophylaxis in acutely Ill hospitalized medical patients: a systematic review and meta-analysis of randomized controlled trials.
Liew AY; Piran S; Eikelboom JW; Douketis JD
J Thromb Thrombolysis; 2017 Apr; 43(3):291-301. PubMed ID: 27900627
[TBL] [Abstract][Full Text] [Related]
25. Comparative effectiveness of combined pharmacologic and mechanical thromboprophylaxis versus either method alone in major orthopedic surgery: a systematic review and meta-analysis.
Sobieraj DM; Coleman CI; Tongbram V; Chen W; Colby J; Lee S; Kluger J; Makanji S; Ashaye A; White CM
Pharmacotherapy; 2013 Mar; 33(3):275-83. PubMed ID: 23401017
[TBL] [Abstract][Full Text] [Related]
26. Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
Matharu GS; Kunutsor SK; Judge A; Blom AW; Whitehouse MR
JAMA Intern Med; 2020 Mar; 180(3):376-384. PubMed ID: 32011647
[TBL] [Abstract][Full Text] [Related]
27. Incidence of Venous Thromboembolism and Benefits and Risks of Thromboprophylaxis After Cardiac Surgery: A Systematic Review and Meta-Analysis.
Ho KM; Bham E; Pavey W
J Am Heart Assoc; 2015 Oct; 4(10):e002652. PubMed ID: 26504150
[TBL] [Abstract][Full Text] [Related]
28. The use of direct oral anticoagulants for extended duration thromboprophylaxis in medically ill patients: a systematic review and meta-analysis.
Alshouimi RA; Al Rammah SM; Alzahrani MY; Badreldin HA; Al Yami MS; Almohammed OA
J Thromb Thrombolysis; 2019 Oct; 48(3):422-429. PubMed ID: 31222563
[TBL] [Abstract][Full Text] [Related]
29. Lack of evidence to support thromboprophylaxis in hospitalized medical patients with cancer.
Carrier M; Khorana AA; Moretto P; Le Gal G; Karp R; Zwicker JI
Am J Med; 2014 Jan; 127(1):82-6.e1. PubMed ID: 24384102
[TBL] [Abstract][Full Text] [Related]
30. Primary thromboprophylaxis (PTP) in ambulatory patients with lung cancer receiving chemotherapy: A systematic review and meta-analysis of randomized controlled trials (RCTs).
Thein KZ; Yeung SJ; Oo TH
Asia Pac J Clin Oncol; 2018 Jun; 14(3):210-216. PubMed ID: 28949077
[TBL] [Abstract][Full Text] [Related]
31. Discordant reporting of VTE in pancreatic cancer: A systematic review and meta-analysis of thromboprophylaxis versus chemotherapeutic trials.
Chiasakul T; Patell R; Maraveyas A; Carrier M; Zwicker JI
J Thromb Haemost; 2021 Feb; 19(2):489-501. PubMed ID: 33174368
[TBL] [Abstract][Full Text] [Related]
32. Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer.
Akl EA; Kahale L; Barba M; Neumann I; Labedi N; Terrenato I; Sperati F; Muti P; Schünemann H
Cochrane Database Syst Rev; 2014 Jul; (7):CD006650. PubMed ID: 25004410
[TBL] [Abstract][Full Text] [Related]
33. Systematic review of randomized controlled trials of new anticoagulants for venous thromboembolism prophylaxis in major orthopedic surgeries, compared with enoxaparin.
Yoshida Rde A; Yoshida WB; Maffei FH; El Dib R; Nunes R; Rollo HA
Ann Vasc Surg; 2013 Apr; 27(3):355-69. PubMed ID: 23351997
[TBL] [Abstract][Full Text] [Related]
34. Nadroparin for the prevention of venous thromboembolism in nonsurgical patients: a systematic review and meta-analysis.
Ageno W; Bosch J; Cucherat M; Eikelboom JW
J Thromb Thrombolysis; 2016 Jul; 42(1):90-8. PubMed ID: 26497987
[TBL] [Abstract][Full Text] [Related]
35. Direct oral anticoagulant versus low-molecular-weight heparin for treatment of venous thromboembolism in cancer patients: An updated meta-analysis of randomized controlled trials.
Haykal T; Zayed Y; Deliwala S; Kerbage J; Ponnapalli A; Malladi S; Goranta S; Samji V; Adam S
Thromb Res; 2020 Oct; 194():57-65. PubMed ID: 32788122
[TBL] [Abstract][Full Text] [Related]
36. Rivaroxaban thromboprophylaxis in ambulatory patients with pancreatic cancer: Results from a pre-specified subgroup analysis of the randomized CASSINI study.
Vadhan-Raj S; McNamara MG; Venerito M; Riess H; O'Reilly EM; Overman MJ; Zhou X; Vijapurkar U; Kaul S; Wildgoose P; Khorana AA
Cancer Med; 2020 Sep; 9(17):6196-6204. PubMed ID: 32663379
[TBL] [Abstract][Full Text] [Related]
37. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
38. Prolonged versus standard-duration venous thromboprophylaxis in major orthopedic surgery: a systematic review.
Sobieraj DM; Lee S; Coleman CI; Tongbram V; Chen W; Colby J; Kluger J; Makanji S; Ashaye AO; White CM
Ann Intern Med; 2012 May; 156(10):720-7. PubMed ID: 22412039
[TBL] [Abstract][Full Text] [Related]
39. Role of Extended Thromboprophylaxis After Abdominal and Pelvic Surgery in Cancer Patients: A Systematic Review and Meta-Analysis.
Fagarasanu A; Alotaibi GS; Hrimiuc R; Lee AY; Wu C
Ann Surg Oncol; 2016 May; 23(5):1422-30. PubMed ID: 26887853
[TBL] [Abstract][Full Text] [Related]
40. Using oral anticoagulants among chronic kidney disease patients to prevent recurrent venous thromboembolism: A systematic review and meta-analysis.
Alhousani M; Malik SU; Abu-Hashyeh A; Poznanski NJ; Al-Hasan S; Roth DF; Alsharedi M; Mustafa B
Thromb Res; 2021 Feb; 198():103-114. PubMed ID: 33310644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
